Nolan Lisa 4
4 · REXAHN PHARMACEUTICALS, INC. · Filed Mar 2, 2018
Insider Transaction Report
Form 4
Nolan Lisa
Chief Business Officer
Transactions
- Exercise/Conversion
Common Stock
2018-02-28+1,625→ 1,625 total - Exercise/Conversion
Restricted Stock Units
2018-02-28+1,625→ 4,875 total→ Common Stock (1,625 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock.
- [F2]On January 20, 2017, the reporting person was granted 6,500 RSUs, of which 1,625 vested on February 28, 2018. The remaining RSUs will vest in three equal annual installments on the last business day in February, beginning February 28, 2019.